Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use

J. Suggett (London (ON), Canada), A. Ellery (London (ON), Canada)

Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Session: Asthma inhalers: devices and adherence studies
Session type: E-poster session
Number: 3181
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Suggett (London (ON), Canada), A. Ellery (London (ON), Canada). Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use. 3181

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New anti-static youth valved holding chamber (VHC) can be used out-of-package and deliver β2-agonist medication effectively
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


In vitro performance of a new non-electrostatic, transparent valved holding chamber (VHC) for the poorly coordinated patient
Source: Eur Respir J 2004; 24: Suppl. 48, 380s
Year: 2004

Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Performance of a valved holding chamber with tracheostomy adapter: comparison with conventional valved holding chamber
Source: Eur Respir J 2001; 18: Suppl. 33, 134s
Year: 2001

Valved holding chamber drug delivery is dependent on breathing pattern and device design
Source: ERJ Open Res, 5 (1) 00158-2018; 10.1183/23120541.00158-2018
Year: 2019



Clinically appropriate testing of different valved holding chamber (VHC)-facemask combinations investigating simulated delivered mass to carina
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015

Are there differences in throat deposition using variable valved holding chambers (VHC)?
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

In-vitro performance of two valved holding chambers (VHCs)/Spacers for paediatric use tested with facemasks attached is unaffected by routine use and cleaning
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Substantial in vitro equivalence exists for non-conducting (NC) and anti-static (AS) valved holding chambers (VHCs) provided pre-conditioning of the non-conducting VHC is undertaken
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Novel non-electrostatic valved holding chamber (VHC) has comparable in vitro performance for delivery of beta-2 agonist as similar-sized, pre-washed but non-conducting VHC
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

Evaluation of robustness of valved holding chambers (VHCs) following repeated dishwasher cycles in-use
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015

Medication delivery testing of valved holding chambers (VHCs) with facemask for infant use by means of a model infant face
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Antistatic valved holding chambers do not necessarily offer similar aerosol delivery performance
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013


In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Improving valved holding chamber (VHC)-face mask fit and function, and patient acceptability
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016